[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1996

The Development of Green Vision in Association With Terbinafine Therapy

Author Affiliations

490 Wonderland Rd S Suite 6 London, Ontario, Canada N6K 1L6

London

Toronto, Ontario

London

Arch Dermatol. 1996;132(7):845-846. doi:10.1001/archderm.1996.03890310137033
Abstract

Terbinafine is one of a new generation of antifungal drugs that is effective in the treatment of dermatophyte infections. It is an allylamine that inhibits the enzyme squalene epoxidase in fungal cell membranes. Adverse events have been reported in 10.4% of the patients receiving this drug.1 We report the development of dyschromatopsia, pruritus, and urticarial le

First Page Preview View Large
First page PDF preview
First page PDF preview
×